Using Nano-Modified Virus Crispr/Cas9 to Overcome Egfr-Tki Resistance in Nsclc (I)

Project title

利用奈米修飾病毒CRISPR/Cas9技術克服非小細胞肺癌EGFR標靶治療之抗藥性(1/3)

Internal ID

109-2124-M-002-012-

Principal Investigator

Start Date

August 1, 2020

End Date

July 31, 2021

Partner Organizations

National Science and Technology Council